General Motors sales rise 1 per cent despite string of safety recalls

Canadian Press DataFile |

DETROIT - General Motors says its U.S. sales rose 1 per cent in June despite a record-setting string of safety recalls.

Sales were led by the Buick Encore small SUV, up 82 per cent. The redesigned Chevrolet Tahoe big SUV also had a strong month with sales almost doubling.

GM sold more than 267,000 vehicles for the month.



GM has recalled nearly 29 million vehicles this year as it reviews years of safety problems. The string began in February with the recall of 2.6 million small cars with faulty ignition switches. GM admitted knowing about the problem for 10 years but it failed to recall the cars until this year.

The website Truecar.com is predicting that total U.S. sales will rise 1 per cent in June. All automakers are scheduled to report sales on Tuesday.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
VEII Value Exchange International Inc 0.03 -0.02 -41.06 1,500

Comments

Emerging Growth

Lexaria Bioscience Corp

Lexaria Bioscience Corp is a food sciences company. It has two distinct consumer product brands: ViPova and Lexaria Energy. It uses patent pending technology to infuse hemp oil ingredients within…

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…